Guangdong Zhongsheng Pharmaceutical Co., Ltd. Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

002317

Rangering i aksjer #4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Aksjekurs
$3.89
Markedsverdi
$3.30B
Endring (1 dag)
-3.14%
Endring (1 år)
43.11%
Land
CN
Handel Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)

Kategori

Healthcare
EPS for Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
EPS per June 2026 TTM: $0.04
Ifølge de siste økonomiske rapportene og aksjekursen til Guangdong Zhongsheng Pharmaceutical Co., Ltd. er selskapets nåværende EPS (TTM) $0.04. Ved slutten av 2024 hadde selskapet en EPS på $-0.05, en nedgang sammenlignet med EPS-en i 2023 som var $0.05.
EPS-historikk for Guangdong Zhongsheng Pharmaceutical Co., Ltd. fra 2006 til 2026
EPS ved slutten av hvert år
År EPS Endre
2026 (TTM) $0.04 -28.20%
2025 $0.05 -195.74%
2024 $-0.05 -209.07%
2023 $0.05 -22.07%
2022 $0.06 5.26%
2021 $0.06 -167.94%
2020 $-0.08 -241.29%
2019 $0.06 -26.88%
2018 $0.08 -1.75%
2017 $0.08 0.88%
2016 $0.08 25.52%
2015 $0.06 26.20%
2014 $0.05 16.55%
2013 $0.04 6.98%
2012 $0.04 20.42%
2011 $0.03 21.98%
2010 $0.03 -1.80%
2009 $0.03 35.61%
2008 $0.02 91.59%
2007 $0.01 42.67%
2006 $0.01 0.00%
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$6.55 18,137.33%
DE
$6.12 16,948.47%
DE
$0.72 1,914.21%
JP
$3.66 10,094.99%
CH
$0.53 1,386.63%
IN